Additionally, it has been hypothesized that the pathophysiology of T2DM may involve mutations in the gene encoding GCGR, further supporting a role for altered glucagon signaling in disease progression [34,35]. The gene discussed is GCGR; the disease is type 2 diabetes mellitus.